- Home
- KPRX vs WISA Comparison
KPRX vs WISA Comparison
Compare KPRX & WISA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPRX
- WISA
- Stock Information
- Founded
- KPRX 1998
- WISA 2010
- Country
- KPRX United States
- WISA United States
- Employees
- KPRX N/A
- WISA N/A
- Industry
- KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- WISA Semiconductors
- Sector
- KPRX Health Care
- WISA Technology
- Exchange
- KPRX Nasdaq
- WISA Nasdaq
- Market Cap
- KPRX 11.0M
- WISA 9.9M
- IPO Year
- KPRX N/A
- WISA 2018
- Fundamental
- Price
- KPRX $3.18
- WISA $2.04
- Analyst Decision
- KPRX Strong Buy
- WISA Buy
- Analyst Count
- KPRX 1
- WISA 2
- Target Price
- KPRX $10.00
- WISA $14.00
- AVG Volume (30 Days)
- KPRX 45.3K
- WISA 600.2K
- Earning Date
- KPRX 11-19-2024
- WISA 11-15-2024
- Dividend Yield
- KPRX N/A
- WISA N/A
- EPS Growth
- KPRX N/A
- WISA N/A
- EPS
- KPRX 1.53
- WISA N/A
- Revenue
- KPRX $16,020,000.00
- WISA $1,789,000.00
- Revenue This Year
- KPRX N/A
- WISA N/A
- Revenue Next Year
- KPRX N/A
- WISA $207.69
- P/E Ratio
- KPRX $2.29
- WISA N/A
- Revenue Growth
- KPRX N/A
- WISA N/A
- 52 Week Low
- KPRX $3.00
- WISA $1.15
- 52 Week High
- KPRX $8.98
- WISA $37.50
- Technical
- Relative Strength Index (RSI)
- KPRX 43.73
- WISA 54.83
- Support Level
- KPRX $3.47
- WISA $1.73
- Resistance Level
- KPRX $3.75
- WISA $2.16
- Average True Range (ATR)
- KPRX 0.22
- WISA 0.12
- MACD
- KPRX -0.03
- WISA 0.01
- Stochastic Oscillator
- KPRX 0.00
- WISA 64.29
About KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About WISA WiSA Technologies Inc.
WiSA Technologies Inc is a provider of immersive, wireless sound technology for intelligent devices and next-generation home entertainment systems through the sale of module components to audio companies as well as audio products to resellers and consumers.. The company works with consumer electronics companies, technology providers, retailers, and ecosystem partners to make immersive audio an enjoyable experience. The company has a geographic presence in Asia Pacific, North America, Europe and, other.